Our providers in Oakton personalize your tirzepatide dosage, ensuring it's tailored to your health profile for optimal results
Afshar, S., Roderick, P
Epithalon stimulates telomerase activity while GHK-Cu enhances collagen and tissue regeneration
Under the program, CMS will waive the current Part D coverage exclusion for weight-loss medications, meaning GLP-1s will be included as a basic benefit of participating plans, and CMS will test different prices negotiated with manufacturers, the use of rebates to keep costs aligned with coverage terms, and cost-sharing options
Start Your Evaluation Your Options Right Now Option 1: Switch to Brand-Name (Wegovy/Ozempic) FDA-approved, no regulatory ambiguity Wegovy costs $1,300+/month without insurance Most insurers still deny coverage for weight loss indication Intermittent supply shortages persist Option 2: Use Insurance Navigation Services Some platforms (Calibrate, Ro) now help with prior authorizations and appeals Approval rates for weight loss indication remain low (3050% depending on insurer) Process takes 26 weeks, during which you have no medication Even if approved, copays often $100$300/month Option 3: Switch to a 503A-Partnered Telehealth Provider Same compounded semaglutide, same price range ($199$399/month) No insurance required HSA/FSA accepted Patient-specific prescriptions within current FDA guidelines No gap in therapy same-day evaluations available Regulatory landscape continues to evolve clinician oversight is critical How to Switch Providers Without Losing Progress If you are currently on a stable dose of semaglutide and need to switch providers, here is the process: Document your current dose and duration
It also lets us walk into your initial appointment with a real plan instead of guessing, we can build the prior authorization around what your specific plan actually requires, rather than submitting a generic file and waiting to see what comes back
:max_bytes(150000):strip_icc()/Health-GLP-1-eating-disorder-93c8465ae7804b7f9bc600c9885bd877.jpg)
